What is the Ideal Technique for Testing the Biocompatibility of Peritoneal Dialysis Solutions?
暂无分享,去创建一个
[1] D. Oreopoulos,et al. Biocompatibility of peritoneal dialysis solutions. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] T. Liberek,et al. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. , 1995, Kidney international.
[3] U. Frei,et al. Peritoneal dialysis fluid biocompatibility: does it really matter? , 1994, Kidney international. Supplement.
[4] N. Topley,et al. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. , 1994, Kidney international. Supplement.
[5] M. Davies,et al. The source and possible significance of hyaluronan in the peritoneal cavity. , 1994, Kidney international.
[6] John D. Williams,et al. Biocompatibility Studies on Peritoneal Cells , 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[7] A. Donker,et al. Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis? , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] N. Topley,et al. In-vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] T. Liberek,et al. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. , 1993, Nephron.
[10] A. Wieslander,et al. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. , 1993, Clinical nephrology.
[11] A. Donker,et al. Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[12] A. Donker,et al. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. , 1993, Clinical nephrology.
[13] T. Liberek,et al. Peritoneal dialysis fluid inhibition of phagocyte function: effects of osmolality and glucose concentration. , 1993, Journal of the American Society of Nephrology : JASN.
[14] T. Liberek,et al. Impact of Peritoneal Dialysis Solutions on Peritoneal Immune Defense , 1993, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[15] A. Donker,et al. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. , 1992, Kidney international.
[16] E. Köttgen,et al. Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. , 1992, American journal of nephrology.
[17] A. Wieslander,et al. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. , 1991, Kidney international.
[18] H. Verbrugh,et al. Cytotoxic Effects of Commercial Continuous Ambulatory Peritoneal Dialysis (CAPD) Fluids and of Bacterial Exoproducts on Human Mesothelial Cells in Vitro , 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[19] A. Sheil,et al. Peritoneal morphology on maintenance dialysis. , 1989, American journal of nephrology.
[20] W. Malaisse,et al. Crabtree effect in tumoral pancreatic islet cells. , 1988, The Journal of biological chemistry.
[21] D. Lloyd,et al. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. , 1986, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] B. Canaud,et al. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study. , 1983, Nephron.
[23] A. Duwe,et al. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro , 1981, Infection and immunity.
[24] D. H. Koobs. Phosphate mediation of the Crabtree and Pasteur effects. , 1972, Science.